Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 92

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 92
---
2642 
         3142642 |     | Expiry Date   
 April 8, 2035 
 April 8, 2035 
 April 8, 2035 |
|:--------|:----|:--------|:----|:--------------|:----|:--------------------|:----|-------------:|:----|:------------------|:----|----------------:|:----|:--------------|
| Granted |     | EP-DK   |     | Oct. 11, 2016 |     | Liposomal Mupirocin |     |      3142642 |     | August 29, 2018   |     |         3142642 |     | April 8, 2035 |
| Granted |     | EP-FR   |     | Oct. 11, 2016 |     | Liposomal Mupirocin |     |      3142642 |     | August 29, 2018   |     |         3142642 |     | April 8, 2035 |
| Granted |     | EP-DE   |     | Oct. 11, 2016 |     | Liposomal Mupirocin |     |      3142642 |     | August 29, 2018   |     |   6020150155610 
    (EP 3142642) |     | April 8, 2035 |
| Granted |     | EP-IE   |     | Oct. 11, 2016 |     | Liposomal Mupirocin |     |      3142642 |     | August 29, 2018   |     |         3142642 |     | April 8, 2035 |
| Granted |     | EP-IT   |     | Oct. 11, 2016 |     | Liposomal Mupirocin |     |      3142642 |     | August 29, 2018   |     | 502018000035029 
    (EP 3142642) |     | April 8, 2035 |
| Granted |     | EP-NL   |     | Oct. 11, 2016 |     | Liposomal Mupirocin |     |      3142642 |     | August 29, 2018   |     |         3142642 |     | April 8, 2035 |
| Granted |